Abstract
Tongxinluo (TXL), a traditional Chinese medicine, can alleviate myocardial ischemia/reperfusion injury (MIRI) by activating eNOS, which exists in both endothelial and non-endothelial cells, such as cardiomyocytes (CMs). Besides, activation of MEK/ERK pathway is reported to account for TXL's
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
